JPMorgan Chase & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.32M | Sell |
|
|||||
|
2025
Q1 | $4.25M | Buy |
|
|||||
|
2024
Q4 | $4.05M | Sell |
|
|||||
|
2024
Q3 | $5.65M | Sell |
|
|||||
|
2024
Q2 | $5.37M | Buy |
|
|||||
|
2024
Q1 | $3.66M | Sell |
|
|||||
|
2023
Q4 | $4.49M | Buy |
|
|||||
|
2023
Q3 | $3.61M | Buy |
|
|||||
|
2023
Q2 | $2.58M | Sell |
|
|||||
|
2023
Q1 | $3.54M | Buy |
|
|||||
|
2022
Q4 | $2.59M | Sell |
|
|||||
|
2022
Q3 | $3.45M | Buy |
|
|||||
|
2022
Q2 | $3.53M | Sell |
|
|||||
|
2022
Q1 | $4.67M | Buy |
|
|||||
|
2021
Q4 | $6.17M | Sell |
|
|||||
|
2021
Q3 | $5.58M | Sell |
|
|||||
|
2021
Q2 | $7.48M | Buy |
|
|||||
|
2021
Q1 | $6.92M | Sell |
|
|||||
|
2020
Q4 | $4.91M | Buy |
|
|||||
|
2020
Q3 | $4.38M | Buy |
|
|||||
|
2020
Q2 | $2.55M | Sell |
|
|||||
|
2020
Q1 | $1.8M | Sell |
|
|||||
|
2019
Q4 | $10.2M | Buy |
|
|||||
|
2019
Q3 | $9.22M | Buy |
|
|||||
|
2019
Q2 | $2.66M | Sell |
|
|||||
|
2019
Q1 | $3.06M | Sell |
|
|||||
|
2018
Q4 | $9.44M | Buy |
|
|||||
|
2018
Q3 | $8.16M | Buy |
|
|||||
|
2018
Q2 | $1.86M | Sell |
|
|||||
|
2018
Q1 | $3.33M | Sell |
|
|||||
|
2017
Q4 | $5.91M | Buy |
|
|||||
|
2017
Q3 | $2.11M | Buy |
|
|||||
|
2017
Q2 | $871K | Buy |
|
|||||
|
2017
Q1 | $627K | Buy |
|
|||||
|
2016
Q4 | $135K | Buy |
|
|||||
|
2016
Q3 | $47K | Sell |
|
|||||
|
2016
Q2 | $465K | Buy |
|
|||||
|
2016
Q1 | $76K | Buy |
|
|||||
|
2015
Q4 | $11K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $953K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $476K | Sell |
|
|||||
|
2013
Q2 | $761K | Buy |
|